NCT02639533View on ClinicalTrials.gov

Brain Response to Single Dose of Pregabalin in Fibromyalgia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Fibromyalgia
Interventions
DRUG

Pregabalin

Pregabalin 150 mg PO, single dose.

OTHER

Placebo

Pill of same physical characteristics as the one used for the intervention, containing starch only. Administered PO in single dose.

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

OTHER_GOV

collaborator

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil

OTHER

lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT02639533 - Brain Response to Single Dose of Pregabalin in Fibromyalgia | Biotech Hunter | Biotech Hunter